Joko K - Search Results

1

Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions-Multicenter analysis.

Hiraoka A, Kumada T, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Tada T, Toyoda H, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Imai M, Joko K, Koizumi Y, Hiasa Y, Michitaka K, Kudo M; Real-life Practice Experts for HCC (RELPEC) Study Group, HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan). Hiraoka A, et al. Among authors: joko k. Cancer Med. 2019 Jul;8(8):3719-3728. doi: 10.1002/cam4.2241. Epub 2019 May 24. Cancer Med. 2019. PMID: 31127698 Free PMC article.

2

Characteristics of lamivudine-resistant hepatitis B virus (HBV) strains with and without breakthrough hepatitis in patients with chronic hepatitis B evaluated by serial HBV full-genome sequences.

Horiike N, Duong TN, Michitaka K, Joko K, Hiasa Y, Konishi I, Yano M, Onji M. Horiike N, et al. Among authors: joko k. J Med Virol. 2007 Jul;79(7):911-8. doi: 10.1002/jmv.20915. J Med Virol. 2007. PMID: 17516520

3

Prospective study of chronic hepatitis C treated with reduced initial ribavirin dose.

Konishi I, Hiasa Y, Nonaka T, Hiraoka A, Joko K, Tokumoto Y, Abe M, Matsuura B, Michitaka K, Horiike N, Onji M. Konishi I, et al. Among authors: joko k. Hepatogastroenterology. 2010 Sep-Oct;57(102-103):1227-31. Hepatogastroenterology. 2010. PMID: 21410063

4

Sustained virological response of patients with hepatitis C virus genotype 2 depends on pegylated interferon compliance.

Watanabe T, Konishi I, Shigematsu S, Uesugi K, Joko K, Seike H, Okada S, Miyaoka H, Nakanishi S, Abe M, Matsuura B, Michitaka K, Horiike N, Hiasa Y, Onji M. Watanabe T, et al. Among authors: joko k. Hepatol Res. 2011 Aug;41(8):722-30. doi: 10.1111/j.1872-034X.2011.00816.x. Epub 2011 Jun 17. Hepatol Res. 2011. PMID: 21682826

5

Complications of radiofrequency ablation for hepatocellular carcinoma in a multicenter study: An analysis of 16 346 treated nodules in 13 283 patients.

Koda M, Murawaki Y, Hirooka Y, Kitamoto M, Ono M, Sakaeda H, Joko K, Sato S, Tamaki K, Yamasaki T, Shibata H, Shimoe T, Matsuda T, Toshikuni N, Fujioka S, Ohmoto K, Nakamura S, Kariyama K, Aikata H, Kobayashi Y, Tsutsui A. Koda M, et al. Among authors: joko k. Hepatol Res. 2012 Nov;42(11):1058-64. doi: 10.1111/j.1872-034X.2012.01025.x. Epub 2012 May 14. Hepatol Res. 2012. PMID: 22583706

6

Clinical features associated with radiological response to sorafenib in unresectable hepatocellular carcinoma: a large multicenter study in Japan.

Takeda H, Nishikawa H, Osaki Y, Tsuchiya K, Joko K, Ogawa C, Taniguchi H, Orito E, Uchida Y, Izumi N; Japanese Red Cross Liver Study Group. Takeda H, et al. Among authors: joko k. Liver Int. 2015 May;35(5):1581-9. doi: 10.1111/liv.12591. Epub 2014 Jun 10. Liver Int. 2015. PMID: 24836552

7

Sorafenib Therapy for BCLC Stage B/C Hepatocellular Carcinoma; Clinical Outcome and Safety in Aged Patients: A Multicenter Study in Japan.

Nishikawa H, Takeda H, Tsuchiya K, Joko K, Ogawa C, Taniguchi H, Orito E, Uchida Y, Osaki Y, Izumi N; Japanese Red Cross Liver Study Group. Nishikawa H, et al. Among authors: joko k. J Cancer. 2014 Jun 7;5(7):499-509. doi: 10.7150/jca.9257. eCollection 2014. J Cancer. 2014. PMID: 24963354 Free PMC article.

8

Comparison of standard-dose and half‑dose sorafenib therapy on clinical outcome in patients with unresectable hepatocellular carcinoma in field practice: A propensity score matching analysis.

Nishikawa H, Osaki Y, Endo M, Takeda H, Tsuchiya K, Joko K, Ogawa C, Taniguchi H, Orito E, Uchida Y, Izumi N; Japanese Red Cross Liver Study Group. Nishikawa H, et al. Among authors: joko k. Int J Oncol. 2014 Dec;45(6):2295-302. doi: 10.3892/ijo.2014.2654. Epub 2014 Sep 16. Int J Oncol. 2014. PMID: 25230744

9

Effects of antiviral therapy for hepatitis C following treatment of hepatocellular carcinoma: survey findings of the Japanese Red Cross Liver Study Group.

Joko K, Goto T, Watanabe H, Mitsuda A, Uchida Y, Hasebe C, Tsuruta S, Kimura H, Koike T, Akamatsu T, Mashiba T, Ochi H, Nakamura Y, Tsuchiya K, Kurosaki M, Izumi N. Joko K, et al. Hepatol Res. 2016 Apr;46(4):251-8. doi: 10.1111/hepr.12515. Epub 2015 Mar 24. Hepatol Res. 2016. PMID: 25753220

10

Targeted DNA and RNA sequencing of fine-needle biopsy FFPE specimens in patients with unresectable hepatocellular carcinoma treated with sorafenib.

Sakai K, Takeda H, Nishijima N, Orito E, Joko K, Uchida Y, Izumi N, Nishio K, Osaki Y. Sakai K, et al. Among authors: joko k. Oncotarget. 2015 Aug 28;6(25):21636-44. doi: 10.18632/oncotarget.4270. Oncotarget. 2015. PMID: 26046304 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters